title: Tuftsin signals through its receptor neuropilin-1 via the transforming growth factor beta pathway.
abstract: Tuftsin (Thr-Lys-Pro-Arg) is a natural immunomodulating peptide found to stimulate phagocytosis in macrophages/microglia. Tuftsin binds to the receptor neuropilin-1 (Nrp1) on the surface of cells. Nrp1 is a single-pass transmembrane protein, but its intracellular C-terminal domain is too small to signal independently. Instead, it associates with a variety of coreceptors. Despite its long history, the pathway through which tuftsin signals has not been described. To investigate this question, we employed various inhibitors to Nrp1's coreceptors to determine which route is responsible for tuftsin signaling. We use the inhibitor EG00229, which prevents tuftsin binding to Nrp1 on the surface of microglia and reverses the anti-inflammatory M2 shift induced by tuftsin. Furthermore, we demonstrate that blockade of transforming growth factor beta (TGFβ) signaling via TβR1 disrupts the M2 shift similar to EG00229. We report that tuftsin promotes Smad3 phosphorylation and reduces Akt phosphorylation. Taken together, our data show that tuftsin signals through Nrp1 and the canonical TGFβ signaling pathway. Despite the 40-year history of the tetrapeptide tuftsin (TKPR), a macrophage and microglial activator, its mechanism of action has not been defined. Here, we report that the tuftsin-mediated anti-inflammatory M2 shift in microglia is caused specifically by tuftsin binding to the receptor neuropilin-1 (Nrp1) and signaling through TGFβ receptor-1, a coreceptor of Nrp1. We further show that tuftsin signals via the canonical TGFβ pathway and promotes TGFβ release from target cells.
authors.affiliation: Program in Molecular and Cellular Pharmacology, Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York, USA.
authors.forename: Jillian C
authors.initials: JC
authors.lastname: Nissen
authors.forename: David L
authors.initials: DL
authors.lastname: Selwood
authors.forename: Stella E
authors.initials: SE
authors.lastname: Tsirka
mesh_terms: D000818:Animals; D015153:Blotting, Western; D002540:Cerebral Cortex / Q000166:cytology; D016207:Cytokines / Q000378:metabolism; D005455:Fluorescent Antibody Technique; D007155:Immunologic Factors / Q000378:metabolism / Q000502:physiology*; D008715:Methionine / Q000502:physiology; D051379:Mice; D008810:Mice, Inbred C57BL; D017628:Microglia / Q000378:metabolism; D009474:Neurons / Q000502:physiology; D039942:Neuropilin-1 / Q000037:antagonists & inhibitors / Q000502:physiology*; D009569:Nitric Oxide / Q000378:metabolism; D061251:Primary Cell Culture; D012313:RNA / Q000096:biosynthesis / Q000302:isolation & purification; D060888:Real-Time Polymerase Chain Reaction; D011956:Receptors, Cell Surface / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*; D016212:Transforming Growth Factor beta / Q000502:physiology*; D014405:Tuftsin / Q000378:metabolism / Q000502:physiology*
chemical_list: D016207:Cytokines; D007155:Immunologic Factors; D011956:Receptors, Cell Surface; D016212:Transforming Growth Factor beta; D039942:Neuropilin-1; D009569:Nitric Oxide; D012313:RNA; D008715:Methionine; D014405:Tuftsin
keywords: anti-inflammatory; cytokines; microglia; neuropilin 1; tuftsin
references.citation: Mol Cell Biol. 2011 Mar;31(6):1174-85
references.pmid: 21245381
references.citation: J Immunol. 2002 Nov 1;169(9):4712-6
references.pmid: 12391178
references.citation: Immunity. 2008 Mar;28(3):402-13
references.pmid: 18328743
references.citation: Peptides. 1999;20(5):645-74
references.pmid: 10465518
references.citation: Proc Natl Acad Sci U S A. 1986 Oct;83(19):7187-91
references.pmid: 3463958
references.citation: Mol Cell Neurosci. 2004 Jan;25(1):162-71
references.pmid: 14962749
references.citation: Nat Immunol. 2002 May;3(5):477-82
references.pmid: 11953749
references.citation: Mol Med Rep. 2012 Apr;5(4):988-92
references.pmid: 22307817
references.citation: Vaccine. 2009 Jan 14;27(3):369-74
references.pmid: 19027810
references.citation: J Cell Biochem. 2007 Oct 15;102(3):593-608
references.pmid: 17729308
references.citation: J Neurosci. 2009 Oct 28;29(43):13435-44
references.pmid: 19864556
references.citation: Nature. 1970 Nov 14;228(5272):672-3
references.pmid: 4097539
references.citation: J Biol Chem. 2006 Nov 10;281(45):33971-81
references.pmid: 16959768
references.citation: BMC Immunol. 2007 Jul 16;8:10
references.pmid: 17634104
references.citation: J Biol Chem. 2006 Mar 3;281(9):5702-10
references.pmid: 16371354
references.citation: Development. 2011 Oct;138(19):4185-91
references.pmid: 21852397
references.citation: J Neurosci. 2002 May 1;22(9):3352-8
references.pmid: 11978811
references.citation: J Neuroimmunol. 2009 May 29;210(1-2):3-12
references.pmid: 19269040
references.citation: Shock. 2011 Aug;36(2):162-9
references.pmid: 21430603
references.citation: J Immunol. 2005 Sep 1;175(5):3025-32
references.pmid: 16116190
references.citation: J Leukoc Biol. 2008 Jul;84(1):302-10
references.pmid: 18436584
references.citation: J Biol Chem. 2010 Oct 8;285(41):31509-16
references.pmid: 20682771
references.citation: Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6152-7
references.pmid: 17405859
references.citation: J Neuroinflammation. 2012 Sep 04;9:210
references.pmid: 22947253
references.citation: J Med Chem. 2010 Mar 11;53(5):2215-26
references.pmid: 20151671
references.citation: Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18169-74
references.pmid: 17978190
references.citation: Biochim Biophys Acta. 1973 May 17;310(1):230-7
references.pmid: 4710594
references.citation: Curr Biol. 1998 Jan 1;8(1):19-25
references.pmid: 9427623
references.citation: Dev Cell. 2003 Jul;5(1):45-57
references.pmid: 12852851
references.citation: J Exp Med. 2006 Dec 25;203(13):2785-91
references.pmid: 17130300
references.citation: Immunity. 2010 May 28;32(5):593-604
references.pmid: 20510870
references.citation: Br J Cancer. 2010 Feb 2;102(3):541-52
references.pmid: 20087344
references.citation: J Exp Med. 2012 Sep 24;209(10):1723-42, S1
references.pmid: 22966001
references.citation: Mol Cancer Ther. 2012 Apr;11(4):1036-47
references.pmid: 22389468
references.citation: Oncoimmunology. 2013 Feb 1;2(2):e23039
references.pmid: 23524975
references.citation: Development. 1995 Dec;121(12):4309-18
references.pmid: 8575331
references.citation: Cell. 1997 Nov 28;91(5):695-704
references.pmid: 9393862
references.citation: J Pain. 2010 Oct;11(10):1004-14
references.pmid: 20434956
references.citation: Cell Res. 2009 Jan;19(1):128-39
references.pmid: 19114990
references.citation: Oncotarget. 2012 Sep;3(9):921-39
references.pmid: 22948112
references.citation: Adv Exp Med Biol. 2002;515:33-48
references.pmid: 12613541
references.citation: PLoS One. 2012;7(4):e34933
references.pmid: 22529957
references.citation: Blood. 2009 Sep 3;114(10):2197-206
references.pmid: 19506300
references.citation: FASEB J. 2006 Jul;20(9):1462-72
references.pmid: 16816121
references.citation: Cell. 1998 Mar 20;92(6):735-45
references.pmid: 9529250
references.citation: Cell Signal. 2011 Jun;23(6):951-62
references.pmid: 20940046